- Home
- FBRX vs ECF Comparison
FBRX vs ECF Comparison
Compare FBRX & ECF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRX
- ECF
- Stock Information
- Founded
- FBRX N/A
- ECF 1986
- Country
- FBRX United States
- ECF United States
- Employees
- FBRX N/A
- ECF N/A
- Industry
- FBRX Biotechnology: Pharmaceutical Preparations
- ECF Finance/Investors Services
- Sector
- FBRX Health Care
- ECF Finance
- Exchange
- FBRX Nasdaq
- ECF Nasdaq
- Market Cap
- FBRX 154.5M
- ECF 150.0M
- IPO Year
- FBRX N/A
- ECF N/A
- Fundamental
- Price
- FBRX $10.92
- ECF $11.20
- Analyst Decision
- FBRX Strong Buy
- ECF
- Analyst Count
- FBRX 3
- ECF 0
- Target Price
- FBRX $68.00
- ECF N/A
- AVG Volume (30 Days)
- FBRX 63.8K
- ECF 57.7K
- Earning Date
- FBRX 08-14-2025
- ECF 01-01-0001
- Dividend Yield
- FBRX N/A
- ECF 6.42%
- EPS Growth
- FBRX N/A
- ECF N/A
- EPS
- FBRX N/A
- ECF 0.46
- Revenue
- FBRX N/A
- ECF N/A
- Revenue This Year
- FBRX N/A
- ECF N/A
- Revenue Next Year
- FBRX N/A
- ECF N/A
- P/E Ratio
- FBRX N/A
- ECF $17.61
- Revenue Growth
- FBRX N/A
- ECF N/A
- 52 Week Low
- FBRX $4.11
- ECF $7.02
- 52 Week High
- FBRX $28.68
- ECF $8.91
- Technical
- Relative Strength Index (RSI)
- FBRX 48.35
- ECF 68.70
- Support Level
- FBRX $10.65
- ECF $10.92
- Resistance Level
- FBRX $11.57
- ECF $11.20
- Average True Range (ATR)
- FBRX 0.93
- ECF 0.16
- MACD
- FBRX -0.04
- ECF 0.01
- Stochastic Oscillator
- FBRX 19.22
- ECF 90.91
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).
About ECF Ellsworth Growth and Income Fund Ltd.
Ellsworth Growth and Income Fund Ltd operate as a closed-end, diversified management investment company. Its investment objective is to provide income and the potential for capital appreciation, which objectives the Fund considers to be relatively equal over the long term due to the nature of the securities in which it invests. The company invests in convertible and equity securities. It invests in various sectors, such as healthcare, financial services, computer software and services, energy and utilities, real estate investment trusts, semiconductors, telecommunications, business services, food and beverage, consumer products, transportation, consumer services among others.